News
New EU project aims to conduct research into new therapies for pancreatic cancer
Professor Daniela Lössner will establish a research group at the Leibniz Institute of Polymer research e.V. (IPF), working on the development of 3D cell culture platforms for research into new therapies for pancreatic cancer. The project is based on the Consolidator Grant from the European Research Council (ERC CoG).
Daniela Lössner will create cancer models in 3D cell cultures by replicating living tissue, combining biological and synthetic material components. This promising, powerful approach is only being pursued by a few scientists worldwide. So far, established models in cancer research are based on tumors from mice and contain undefined amounts of extracellular matrix and growth factors. The 3D cancer model that Daniela Lössner plans to develop will reflect the composition of the tissue more realistically and allow patient-specific recreation of the pancreatic tumor environment and its structural and biomechanical properties.
Daniela Lössner is convinced that will make it much easier to study, understand and predict how tumors behave in patients and how malignant and non-malignant cells respond to novel treatments.
ERC Consolidator Grants are among the most highly endowed and prestigious funding awards of the European Union. They are awarded to established top researchers who have already achieved excellent research results.
07.04.2021